metaproterenol has been researched along with Cardiac Conduction Defect in 2 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FRIESE, G | 1 |
| THORSPECKEN, R | 1 |
| KNOPP, A | 1 |
2 other studies available for metaproterenol and Cardiac Conduction Defect
| Article | Year |
|---|---|
[First experiences with Alupent in the treatment of atrioventricular conduction disorders of the heart].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Block; Heart Conduc | 1961 |
[CLINICO-THERAPEUTIC EXPERIENCES WITH ALUPENT IN DEFECTS OF THE RHYTHM CENTER AND CONDUCTION SYSTEM OF THE HEART].
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Di | 1964 |